Authors
Loading...
Preclinical study reveals that selective mGlu1 receptor activation restores prefrontal inhibition and cognitive function in mice, indicating a potential therapeutic strategy for schizophrenia.
Luessen et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: